| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 326.97× | 326.97× | 1,107.61× | 1,355.43× | 2,262.87× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.52× | 0.41× | 0.25× | 0.46× | 0.35× | ||
| 0.51× | 0.51× | 0.22× | 0.18× | 0.11× | ||
| 0.10× | 0.10× | −2.48× | −3.14× | −6.60× | ||
| 0.07× | 0.07× | −1.14× | −1.25× | −1.22× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 2,262.87 | 1,355.43 | 1,107.61 | 326.97 | 326.97 | |
| Working Capital Turnover | 0.35 | 0.46 | 0.25 | 0.41 | 0.52 | |
| Asset Turnover | 0.11 | 0.18 | 0.22 | 0.51 | 0.51 | |
| Cash Conversion (CFO/Net Income) | -6.60 | -3.14 | -2.48 | 0.10 | 0.10 | |
| CFO/EBITDA | -1.22 | -1.25 | -1.14 | 0.07 | 0.07 |